• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314
Citation: LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314

Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus

More Information
  • The aim of study was to determine the relationship between the biomarker of glucose and lipid metabolism and NG, NG′-asymmetric dimethylarginine(ADMA), total homocysteine(tHcy), adiponectin(APN)and pentraxin 3(PTX3)in type 2 diabetes mellitus rats. Diabetes was induced in Sprague-Dawley rats by a single intraperitoneal injection of 35mg/kg streptozotocin(STZ). Before and 2nd, 4th, 7th, 9th weeks after STZ injection, fasting plasma glucose(FPG), fasting insulin(FINS), OGTT, serum lipid(TC, TG and LDL-C), ADMA, tHcy, APN, PTX3 were determined. Compared with the groups of control and high fat diet(HFD), FPG, Homeostasis model assessment for insulin resistence index(HOMA-IR), TC, TG and LDL-C level of type 2 diabetes mellitus(T2DM)groups were significantly increased. In T2DM group, the concentration of ADMA increased gradually, tHcy decreased by degrees, APN reduced significantly, the PTX3 elevated remarkably. Our results indicate that ADMA, tHcy, APN, PTX3 are well correlated with glucose and lipid metabolism biomarkers. The plurality of biomarkers mentioned before should be monitored to evaluate the cardiovascular risk of type 2 diabetes mellitus.
  • Related Articles

    [1]WANG Yingxin, LIU Ling, LI Shuying, LAN Yi, NIE Lei. Analysis of related substances in montelukast sodium granules by HPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(3): 330-336. DOI: 10.11665/j.issn.1000-5048.20190309
    [2]DING Xiying, JI Xiaolong, LI Bo, MAO Baiyang, YAN Fang, DI Bin. Determination of potential genotoxic impurity in ecabet sodium active pharmaceutical ingredient by HPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2018, 49(3): 317-321. DOI: 10.11665/j.issn.1000-5048.20180310
    [3]Determination of Telmisartan in Human Plasma by HPLC-MS and Study of Its Pharmacokinetics[J]. Journal of China Pharmaceutical University, 2004, (6): 64-67.
    [4]Quantitation of Donepezil in Human Plasma by HPLC-MS[J]. Journal of China Pharmaceutical University, 2004, (1): 38-41.
    [5]Determination of Cyclosporin A in Ocular Tissues by HPLC-MS[J]. Journal of China Pharmaceutical University, 2003, (4): 44-47.
    [6]Determination of Zaleplon in Human Plasma by HPLC-MS[J]. Journal of China Pharmaceutical University, 2003, (4): 40-43.
    [7]Determination of Amoxicillin and Clavulnanic Acid in Human Plasma by HPLC-MS[J]. Journal of China Pharmaceutical University, 2002, (1): 26-29.
    [8]Determination of Aspirinand Salicylic acid in human Plasma by LC-MS and HPLC-UV[J]. Journal of China Pharmaceutical University, 2001, (1): 49-52.
    [9]Determination of Methandienone and Its Metabolite in Human Urine by HPLC[J]. Journal of China Pharmaceutical University, 1991, (2): 83-85.
    [10]Determination of Creatinine in Serum and Urine by the Airsegmented Flow Injection Analysis[J]. Journal of China Pharmaceutical University, 1990, (5): 302-304.
  • Cited by

    Periodical cited type(4)

    1. 俞嘉斌,邹波,魏春明,董林沛,赵鹏,宋祥瑞,吴小军,张云峰,杨瑞琴. 全自动在线前处理技术在法庭科学毒物分析中的应用. 分析试验室. 2023(03): 406-415 .
    2. 陈军. 环境有机污染物检测现状探讨. 广东化工. 2022(03): 143-144 .
    3. 王卿,姜红,郑珲. 不同基质中常见毒品检测方法研究进展. 化学研究与应用. 2021(03): 393-399 .
    4. 康明星,宋爱英,苏文渊. 固相微萃取技术在滥用药物分析中的应用进展. 化学研究与应用. 2020(08): 1313-1320 .

    Other cited types(4)

Catalog

    Article views (1077) PDF downloads (1821) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return